Immunotherapy vs chemotherapy: how to compare the treatment that fits your cancer

Understand what each treatment is doing

Chemotherapy uses medicines that kill cancer cells or interfere with their growth. Because some healthy tissues also contain rapidly dividing cells, treatment can affect blood counts, the mouth, digestion or hair, depending on the drugs used.

Immunotherapy is a broad group. The most common comparison with chemotherapy concerns checkpoint inhibitors, such as PD-1 or PD-L1 medicines, which help immune cells respond to cancer. Cell therapies and cancer vaccines are different forms of immunotherapy with their own treatment processes. Ask which type is actually being proposed.

Sources and references: [1] [2]

Start with the cancer and treatment setting

The choice depends on the tissue diagnosis, stage and what treatment has already been given. A medicine useful in one cancer or treatment line may have a different role in another. Ask the oncologist to explain the purpose of the regimen in your specific setting.

Biomarkers such as PD-L1, mismatch-repair status or particular molecular changes may influence immune-treatment choices. Their importance varies by disease and regimen. Request the complete test result and ask what it changes: the preferred medicine, the need for combination treatment or eligibility for a trial.

Sources and references: [2] [3]

Why a plan may use both

Some regimens combine chemotherapy and immunotherapy because the combination has evidence in the relevant disease setting. Chemotherapy may be given for a defined initial phase while the immune medicine continues longer, or the schedule may be different for your cancer.

Ask for a calendar showing each drug, the reassessment point and any maintenance phase. Understanding which component continues helps with planning appointments and interpreting side effects. If one drug is paused, ask whether the others continue and how that affects the goal of the regimen.

Sources and references: [1] [2]

Compare outcomes that matter to your decision

Ask what benefit the recommended plan is expected to provide: reducing recurrence risk after surgery, shrinking a tumor before local treatment or controlling advanced disease. Those are different uses, and the evidence should match the one you face.

When looking at study results, ask which patients were included, what the comparison treatment was and what outcome improved. Then connect that information to your health and priorities. A useful discussion also covers how soon treatment needs to work and what the team will do if symptoms worsen before the first planned scan.

Sources and references: [1] [4]

Prepare for different patterns of side effects

Chemotherapy can cause fatigue, nausea, low blood counts, mouth soreness or nerve symptoms, with the pattern depending on the medicine. Ask which problems are most likely with your regimen and what prevention or treatment is available. Many patients find a written medication and symptom plan helpful.

Checkpoint inhibitors can cause immune-related inflammation affecting organs such as the bowel, lungs, liver or hormone glands. New persistent diarrhea, breathing changes or severe unexplained fatigue should be reported promptly. Keep the treatment names available when seeing another doctor, including after an immune medicine has stopped.

Sources and references: [1] [2]

Review conditions that affect treatment safety

Heart, kidney or liver disease and existing neuropathy may influence chemotherapy selection. Autoimmune disease, organ transplantation and medicines that suppress immunity need particular discussion before checkpoint inhibition. The team assesses these alongside the expected cancer benefit.

Bring a complete medication list, including supplements and recent steroid use. Ask what baseline tests are needed and which clinician will review abnormal results. If you have previously stopped treatment because of a serious reaction, send the relevant hospital records so the next team can understand exactly what happened.

Sources and references: [1] [2]

Use scans and symptoms to assess progress

Feeling fewer side effects is not a measure of weaker treatment. The team assesses response through the appropriate scans, examination and laboratory tests, while considering symptoms and daily function. Ask when the first reassessment will occur and what result would change the plan.

Keep a short record of energy, appetite, pain and any new symptoms between visits. If you travel for care, agree on where blood tests and imaging can be done after returning home. A clear communication route helps the treating team respond to problems without waiting for the next journey.

Sources and references: [1] [2]

Arrange a regimen review that answers your question

Fudan University Shanghai Cancer Center has multiple disease-specific oncology services. A useful consultation can compare a chemotherapy regimen, an immune regimen or their combination in the context of your diagnosis and prior care.

Send EastMedGo the pathology, staging scans, biomarker results and previous treatment list. Tell us which choice you are weighing and what concerns you most, such as neuropathy, autoimmune disease or time away from home. We can organize a focused consultation request and help coordinate records and practical planning around the proposed treatment.

Sources and references: [5]

Common questions